The Guatemalan man told officials he had colon cancer when he first arrived at Otay Mesa Detention Center, according to his medical records.

Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer.

New research out of VCU Massey Comprehensive Cancer Center—published in Brain, Behavior and Immunity—is the first to suggest that a tumor-driving gene known as AEG-1 actively regulates the ...

Sarah Sessoms, chief operating officer of Community Health Works, which provides low-cost and mobile cancer screening, recommended that the legislature make nonprofit hospitals report the number of ...

A special committee of the Georgia House of Representatives is traveling the state to hear about access to cancer care.

A proposed $21 million cancer center at Southwestern Vermont Medical Center could be close to receiving permitting approval ...

ATLANTA – Cancer care is hard to come by in rural Georgia, as the medical payments system squeezes smaller service providers amid traditional challenges such as rising costs and inadequate ...

Patients who experience inadequate response or intolerance to tumour necrosis factor inhibitors (TNFi-IR) are of clinical interest, particularly as second-line biologic treatments typically ...

and inadequate or fragmented treatment,’’ the paper states. The NAMS’s task force is also looking into developing guidelines for stakeholders involved in combating breast cancer across the ...

“Pancreatic cancer has the highest mortality rate of any common cancer and thus current treatments are woefully inadequate,” said Dr. Andrew Lowy, professor at UC San Diego School of Medicin ...

There are limited comparisons of long-term outcomes between adequate and inadequate BCG ... inverse probability of treatment weighting (IPTW)-adjusted Kaplan-Meier curves and IPTW-adjusted ...

This statistic underscores that although cutting-edge treatments are readily ... is needed when reducing the doses of cancer therapies. “There is inadequate knowledge on what level of dose ...